Development of Improved DNA Vaccines and Electroporation Delivery Devices for HIV

Viral Genomix, Inc., Blue Bell PA

Investigators

Abstract

The purpose of this contract is to develop an innovative preventive HIV vaccine concept into a HIV Vaccine product(s) suitable for testing in humans. The contractor is required to enter into a HIV Vaccine product into a clinical trial by the fifth year.